VectraCor was awarded First Place National winner for the Pitching Across America competition for Emerging Companies. VectraCor has patented technology that can detect a heart attack in real time and derive a 12-22 lead ECG with only 5 electrodes on a patient. This technology is very disruptive to the current practices, and potentially reduces costs and time to diagnose a heart attack.
Totowa, New Jersey - VectraCor, Inc., a NJ medical device company, has been named the Top Emerging Company in America - 2010 of the FundingPost Sevent ...
Satisfied Users & 
Approved Press Releases
